p38α and p38δ mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells

[1]  K. Ang,et al.  Head and Neck Cancers , 2011 .

[2]  D. Brachman,et al.  Occurrence of p 53 Gene Deletions and Human Papilloma Virus Infection in Human Head and Neck Cancer 1 , 2006 .

[3]  G. Casey,et al.  Frequent p 53 Mutations in Head and Neck Cancer ' , 2006 .

[4]  P. Harrison,et al.  Profiling early head and neck cancer , 2005, Nature Reviews Cancer.

[5]  R. Ala-aho,et al.  Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo , 2004, Oncogene.

[6]  P. Hofmann,et al.  Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes. , 2004, American journal of physiology. Heart and circulatory physiology.

[7]  J. Olson,et al.  p38 MAP kinase: a convergence point in cancer therapy. , 2004, Trends in molecular medicine.

[8]  K. Reddy,et al.  Role of MAP kinase in tumor progression and invasion , 2003, Cancer and Metastasis Reviews.

[9]  Jiahuai Han,et al.  p38 Mitogen-activated protein kinase pathway suppresses cell survival by inducing dephosphorylation of mitogen-activated protein/extracellular signal-regulated kinase kinase1,2. , 2020, Cancer research.

[10]  R. Eckert,et al.  A Regulatory Role for p38δ MAPK in Keratinocyte Differentiation , 2003, Journal of Biological Chemistry.

[11]  Jiahuai Han,et al.  p38 Isoforms Have Opposite Effects on AP-1-dependent Transcription through Regulation of c-Jun , 2003, The Journal of Biological Chemistry.

[12]  Emma Black,et al.  Negative Feedback Regulation of MKK6 mRNA Stability by p38α Mitogen-Activated Protein Kinase , 2003, Molecular and Cellular Biology.

[13]  Jiahuai Han,et al.  p38 Mitogen-activated Protein Kinase Pathway Suppresses Cell Survival by Inducing Dephosphorylation of Mitogen-activated Protein/Extracellular , 2003 .

[14]  Emma Black,et al.  Negative feedback regulation of MKK6 mRNA stability by p38alpha mitogen-activated protein kinase. , 2003, Molecular and cellular biology.

[15]  Xiang Guo,et al.  Head and neck cancers. , 2003, Cancer chemotherapy and biological response modifiers.

[16]  Jiahuai Han,et al.  Activation of p38α MAPK Enhances Collagenase-1 (Matrix Metalloproteinase (MMP)-1) and Stromelysin-1 (MMP-3) Expression by mRNA Stabilization* , 2002, The Journal of Biological Chemistry.

[17]  C. Der,et al.  Raf-independent Deregulation of p38 and JNK Mitogen-activated Protein Kinases Are Critical for Ras Transformation* , 2002, The Journal of Biological Chemistry.

[18]  Albert J. Fornace,et al.  Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity , 2002, Nature Genetics.

[19]  V. Kähäri,et al.  Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets , 2002, International journal of cancer.

[20]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[21]  R. Grenman,et al.  Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells , 2002, Oncogene.

[22]  Jiahuai Han,et al.  p38 Mitogen-Activated Protein Kinase-Dependent Activation of Protein Phosphatases 1 and 2A Inhibits MEK1 and MEK2 Activity and Collagenase 1 (MMP-1) Gene Expression , 2001, Molecular and Cellular Biology.

[23]  J. Aguirre-Ghiso,et al.  Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. , 2001, Molecular biology of the cell.

[24]  J. Westermarck,et al.  Activation of fibroblast collagenase-1 expression by tumor cells of squamous cell carcinomas is mediated by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase-2. , 2000, Cancer research.

[25]  G. Nemerow,et al.  Urokinase Plasminogen Activator/Urokinase-specific Surface Receptor Expression and Matrix Invasion by Breast Cancer Cells Requires Constitutive p38α Mitogen-activated Protein Kinase Activity* , 2000, The Journal of Biological Chemistry.

[26]  H. Enslen,et al.  Molecular determinants that mediate selective activation of p38 MAP kinase isoforms , 2000, The EMBO journal.

[27]  C. López-Otín,et al.  Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. , 2000, Journal of cell science.

[28]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[29]  G. Nemerow,et al.  Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity. , 2000, The Journal of biological chemistry.

[30]  Jiahuai Han,et al.  The p38 signal transduction pathway: activation and function. , 2000, Cellular signalling.

[31]  Jiahuai Han,et al.  Transforming Growth Factor-β Induces Collagenase-3 Expression by Human Gingival Fibroblasts via p38 Mitogen-activated Protein Kinase* , 1999, The Journal of Biological Chemistry.

[32]  K. Sakaguchi,et al.  Phosphorylation of human p53 by p38 kinase coordinates N‐terminal phosphorylation and apoptosis in response to UV radiation , 1999, The EMBO journal.

[33]  C. Manthey,et al.  Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages. , 1999, Journal of immunology.

[34]  G L Johnson,et al.  Organization and regulation of mitogen-activated protein kinase signaling pathways. , 1999, Current opinion in cell biology.

[35]  D. Johnson,et al.  Purification and activation of recombinant p38 isoforms alpha, beta, gamma, and delta. , 1998, Protein expression and purification.

[36]  D. Boyd,et al.  Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. , 1998, Cancer research.

[37]  J Ross,et al.  Cardiac Muscle Cell Hypertrophy and Apoptosis Induced by Distinct Members of the p38 Mitogen-activated Protein Kinase Family* , 1998, The Journal of Biological Chemistry.

[38]  Roger J. Davis,et al.  Selective Activation of p38 Mitogen-activated Protein (MAP) Kinase Isoforms by the MAP Kinase Kinases MKK3 and MKK6* , 1998, The Journal of Biological Chemistry.

[39]  R. Grenman,et al.  Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. , 1997, The American journal of pathology.

[40]  C. López-Otín,et al.  Expression of collagenase-3 in the rat ovary during the ovulatory process. , 1996, The Journal of endocrinology.

[41]  Michael E. Greenberg,et al.  Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.

[42]  G. Casey,et al.  Frequent p53 mutations in head and neck cancer. , 1992, Cancer research.

[43]  D. Brachman,et al.  Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. , 1992, Cancer research.

[44]  G. Wilkinson,et al.  Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. , 1992, Nucleic acids research.

[45]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[46]  S. Boyce,et al.  Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. , 1983, The Journal of investigative dermatology.

[47]  G. Klein,et al.  Cellular reactions against Burkitt lymphoma cells. III. Effector cell activity of leukocytes stimulated in vitro with autochthonous cultured lymphoma cells , 1972, International journal of cancer.